NTN BUZZTIME, INC.

Company

Ernexa Therapeutics Inc.

Filed

March 31, 2010

Period of Report

December 31, 2009

Accession Number

0001019687-10-001222

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →